Free Trial
NASDAQ:PRE

Prenetics Global 9/15/2023 Earnings Report

Prenetics Global logo
$7.76 -0.25 (-3.06%)
As of 03:51 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Prenetics Global EPS Results

Actual EPS
-$0.75
Consensus EPS
-$0.90
Beat/Miss
Beat by +$0.15
One Year Ago EPS
N/A

Prenetics Global Revenue Results

Actual Revenue
$5.70 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Prenetics Global Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Prenetics Global's next earnings date is estimated for Monday, October 6, 2025, based on past reporting schedules.

Conference Call Resources

Prenetics Global Earnings Headlines

Amazon’s big Bitcoin embarrassment
Bitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. While the crowd buys Bitcoin outright, trader Larry Benedict is using a method called “Bitcoin Skimming” to target 6x, 9x, even 22x bigger profits. He reveals how it works in a free video.
PRE Prenetics Global Limited - Seeking Alpha
Prenetics Global Limited (PRE) - Yahoo Finance
See More Prenetics Global Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Prenetics Global? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Prenetics Global and other key companies, straight to your email.

About Prenetics Global

Prenetics Global (NASDAQ:PRE), a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.

View Prenetics Global Profile

More Earnings Resources from MarketBeat